Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 38.40
+2.90 (8.17%)
Sep 25, 2026, 11:25 AM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 73.32 million as of September 24, 2026. Its market cap has decreased by -65.53% in one year.
Market Cap
73.32M
Enterprise Value
61.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38.40
ChartMarket Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 73.32M, an increase of 37.15%. That is a compound annual growth rate of 2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 73.32M | -64.40% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 284.41M |
| Scancell Holdings | 117.59M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Poolbeg Pharma | 69.09M |
| Ondine Biomedical | 55.85M |
| Sareum Holdings | 42.96M |
| Arecor Therapeutics | 33.04M |